FARMINGDALE, NY, February 1, 2012 – Pedinol Pharmacal Inc. today announced that it is advising healthcare professionals, pharmacists and patients of a potential problem with Gris-PEG® (griseofulvin ultramicrosize) 125mg and 250mg manufactured and packaged by Novartis Consumer Health at its Lincoln, Nebraska manufacturing site. Due to problems that occurred when these products were packaged and labeled at the site, tablets from one product type may have carried over into packaging of another product. This could result in a stray pill of one medicine ending up in the bottle of another product. After a thorough analysis, Pedinol estimates the likelihood of this occurring in medication dispensed to patients is low.

Pedinol reports that they are not aware of any product mix-ups with respect to these products since 2009. Pedinol is not aware of any patient having experienced a confirmed product mix-up nor any adverse events attributable to product mix-up. Nonetheless, to ensure continued patient safety and access to these needed medicines, Pedinol advises healthcare professionals, pharmacists and patients to examine Gris-PEG® tablets in their possession and ensure that all tablets are the same. Pedinol is providing instructions on how to identify an incorrect tablet in these medicines.

“We are committed to ensuring that all healthcare professionals, pharmacists and patients are aware of this very low risk,” said Gary Strauss, CEO of Pedinol. “We are also committed to ensuring the highest standard for patients who rely on our product.”

The likelihood of finding a wrong tablet in Gris-PEG® dispensed to patients is low and patients should not be unduly alarmed. For medications already in homes and pharmacies, there are simple steps provided at www.pedinol.com and www.grispeg.com to identify affected products.

For any questions, patients should contact Pedinol Pharmacal Inc. at 1-800-733-4665 or ask their pharmacist or doctor for additional help in identifying whether there are any problems with their medication.

Here at PEDiNOL™, we are constantly striving to improve our customer service, as it is a vital part of our company and commitment to Podiatry. We have recently taken another step to better assist you by improving our product packaging.

Our new package design is clean, easy to read, and features a category-specific color coding system allowing both you and your patients to quickly and correctly identify the different product lines we offer: Drying, Antifungal, Moisturizer, Wart, Blister/Wound Care, Office Use and Miscellaneous. In addition, important information is clearly displayed on the new packaging, including the item number, scientific name, product description and contents/size. This new packaging helps Podiatrists, Pharmacists and patients understand a PEDiNOL product’s intended use at a glance.

So now it’s even easier to make an informed choice on all your over-the-counter, in-office and continued patient care PEDiNOL products, many of which were developed with specific input from Podiatrists, with 14 proudly displaying the APMA Seal of Approval.

If you have any questions about our new label or any of our products, and would like to speak to a live representative, please do not hesitate to call us at 1.800.PEDiNOL (1.800.733.4665), Monday through Friday from 9 AM – 5 PM EST (excluding holidays). You may also visit our website at www.pedinol.com.

Farmingdale, NY—August 1, 2011—PEDiNOL has launched the all new Sleep-N-Heel TM Rejuvenating Kit, an at-home heel renewal kit designed to soften dry, cracked skin on the feet with a gel-pad heel sleeve, a urea based moisturizer and an exfoliating foot soap.

“One of our goals at Pedinol is to help podiatrists make treatment options as easy as possible for their patients”, says Gary Strauss, Chief Executive Officer of PEDiNOL. “The Sleep-N-Heel Kit does that by bringing three terrific products – Sleep-N-Heel TM, Exfolix TM and Ureacin®-20 Cream – together in one easy to use kit for patients. All three products will help podiatrists and their patients treat dry, cracked heels, which tend to be so prevalent in podiatric patients.”

Sleep-N-Heel™ Night Conditioning Heel Sleeves provide relief to rough or cracked heels by moisturizing dry skin at night while you rest. Exfolix provides exfoliating, cleansing and anti-bacterial benefits in one soap bar. Ureacin-20 is a thick, rich cream that dissolves dry outer layers of skin and stimulates skin cell renewal using an effective moisturizer.

PEDiNOL’s President, Richard Strauss, R.Ph, states, “We carefully chose products that we knew would work well together in this three step kit, to moisturize & rejuvenate dry, cracked skin on the feet. Exfolix removes dry, rough skin with its exfoliating action, Ureacin-20 moisturizes and rehydrates the skin and Sleep-N-Heel helps to maintain smooth, healthy skin.”

To learn more about the Sleep-N-Heel Kit, or to place an order, visit www.pedinol.com or call 1-800-PEDiNOL (733-4665).

About PEDiNOL:

PEDiNOL is based in Farmingdale, NY and was founded in 1925 by Dr. Harry Goldwag, a podiatrist. Since that time, PEDiNOL’s mission has been to provide podiatrists with safe and effective products for their patients’ needs. PEDiNOL’s products include Gris-PEG® (griseofulvin ultramicrosize) Tablets USP 125mg; 250mg. Fourteen of PEDiNOL’s products bear the APMA Seal of Approval. For more information, please visit our website at www.pedinol.com or call us, toll free, at 1-800-PEDiNOL (733-4665). Live PEDiNOL representatives are available Monday through Friday, 9 AM until 5 PM EST, except holidays.

NWHS0711SD01

Farmingdale, NY—August 1, 2011—PEDiNOL combines the strength of tolnaftate 1% with a moisturizer in one tube to create Fungoid-D antifungal cream, an effective solution to athlete’s foot and dry skin.

There are many ways to treat athlete’s foot, but results may not always be lasting because it may reoccur if the fungus is not completely stopped. In order to solve this problem, PEDiNOL developed Fungoid-D, an everyday cream with the triple advantage of treating athlete’s foot, preventing its reoccurrence and moisturizing feet, all at once.

“From working with Podiatrists, we know that tinea pedis is a painful and embarrassing condition that often does not disappear with one treatment”, states Gary Strauss, Chief Executive Officer of PEDiNOL. “Prevention is a major factor when it comes to managing patients’ athlete’s foot. When used daily, Fungoid-D prevents and clears up most athlete’s foot infections, while smoothing dry skin on the feet.”

There are many uncomfortable side effects that are associated with athlete’s foot, including dry, cracked skin. Unlike most antifungal products currently available on the market, Fungoid-D moisturizes dry skin while treating athlete’s foot, leaving feet feeling soft and refreshed.

PEDiNOL’s President, Richard Strauss, RPh, is very proud of this product launch, saying, “PEDiNOL has always been known to provide Podiatrists with effective antifungal and moisturizing products. Many patients struggle with both athlete’s foot and dry skin. I’m excited to offer them an over-the-counter antifungal product, which treats both of these problems.”

Fungoid-D is available in a 4 oz. tube. To learn more about Fungoid-D antifungal cream, or to place an order, visit www.pedinol.com or call 1-800-PEDiNOL (733-4665).

About PEDiNOL:

PEDiNOL is based in Farmingdale, NY and was founded in 1925 by Dr. Harry Goldwag, a podiatrist. Since that time, PEDiNOL’s mission has been to provide podiatrists with safe and effective products for their patients’ needs. PEDiNOL’s products include Gris-PEG® (griseofulvin ultramicrosize) Tablets USP 125mg; 250mg. Fourteen of PEDiNOL’s products bear the APMA Seal of Approval. For more information, please visit our website at www.pedinol.com or call us, toll free, at 1-800-PEDiNOL (733-4665). Live PEDiNOL representatives are available Monday through Friday, 9 AM until 5 PM EST, except holidays.

NWFD0611SD01

Farmingdale, NY—June 23, 2011—PEDiNOL has announced the introduction of Exfolix foot soap, designed to exfoliate and cleanse dry, rough skin on the feet.

“As a podiatry company, PEDiNOL is always looking for new and innovative products that will bring value to podiatrists and their patients”, states Gary Strauss, Chief Executive Officer of PEDiNOL. “Exfolix foot soap fits that bill. Podiatry patients will benefit from the exfoliating, cleansing and antibacterial action of Exfolix.”

Exfoliation is the key to smooth healthy skin because it gets rid of dead skin cells on the outer layer of skin and makes skin softer and smoother. An effective yet gentle soap, Exfolix offers an excellent alternative to traditional exfoliating methods. Unlike a pumice stone, Exfolix provides exfoliating, cleansing and antibacterial benefits in one soap bar.

 “We are known for our foot care products, so it only makes sense to develop soap specially designed just for the feet”, says President of PEDiNOL, Richard Strauss, RPh. “Exfolix is a great addition to our current line of foot care products and can be used as a complement to many of our existing moisturizing products”.

Natural ingredients such as orange peel oil and furocoumarin free bergamot oil, give Exfolix a fresh citrus scent that all podiatry patients will love. Exfolix works great on its own, and can also be used with one of PEDiNOL’s specialty moisturizers, such as Lactinol^® HX, Ureacin^® Creme and Lotion, or Hydrisinol^® Creme and Lotion. To learn more about Exfolix foot soap, or to place an order, visit our website at www.pedinol.com or call us at 1-800-PEDiNOL (733-4665).

About PEDiNOL:

Farmingdale, NY—May 20, 2011—PEDiNOL has launched a gel heel sleeve, Sleep-N-Heel Night Conditioning Heel Sleeves, to provide soothing relief to rough cracked heels by moisturizing dry skin while resting.

Rough or cracked heels are common foot problems which result from various factors and circumstances. Dry, cracked heels are unattractive and embarrassing, especially for those who love to wear sandals or open-backed shoes. PEDiNOL developed Sleep-N-Heel Night Conditioning Heel Sleeves, which are designed to smooth & soften rough, dry skin on feet, just in time for the summer months.

Gary Strauss, CEO of PEDiNOL, explains “Everyone wants smooth, soft heels, but not everyone has the time, energy or money to care for their feet properly. Now, PEDiNOL has made achieving soft heels incredibly easy - just slide on a pair of Sleep-N-Heel Night Conditioning Heels Sleeves before bed and let them moisturize and soften your skin while you rest. It’s that simple.”

Each Sleep-N-Heel Night Conditioning Heel Sleeve is molded with a soft, fragrance-free pad lining that comfortably conforms to the shape of the heel. Using a patent-pending technology, this proprietary triglyceride polymer gel is designed to slowly release a unique blend of natural moisturizers. Enriching essential oils- such as coconut, jojoba and olive oil- provide deep conditioning and continuous hydration to impart needed moisture, while vitamin E and shea butter supply a potent source of antioxidants and other nutrients that promote healthy skin renewal and rejuvenate the skin’s appearance.

“Sleep-N-Heel Night Conditioning Heel Sleeves provide a significant opportunity to offer podiatrists and their patients an innovative solution for the widespread problem of dry skin”, says PEDiNOL’s President, Richard Strauss, RPh. “When worn regularly, they can prevent or reverse cracks and calluses as well as preserve the comfort and cosmetic advantages of soft, smooth heels.”

Sleep-N-Heel Night Conditioning Heels Sleeves are dermatologist tested, hypoallergenic, latex-free and mineral oil-free. They are effective and reusable for up to 40 treatments. Order a pair today by visiting www.pedinol.com or by calling 1-800-PEDiNOL. Don’t forget to use free shipping code SNHFS when you checkout.

About PEDiNOL:

PEDiNOL is based in Farmingdale, NY and was founded in 1925 by Dr. Harry Goldwag, a podiatrist. Since that time, PEDiNOL’s mission has been to provide podiatrists with safe and effective products for their patients’ needs. PEDiNOL’s products include Gris-PEG® (griseofulvin ultramicrosize) Tablets USP 125mg; 250mg. Fourteen of PEDiNOL’s products bear the APMA Seal of Approval. For more information, please visit our website at www.pedinol.com or call us, toll free, at 1-800-PEDiNOL (733-4665). Live PEDiNOL representatives are available Monday through Friday, 9 AM until 5 PM EST, except holidays.

NWHS0511SD01

FARMINGDALE, NY—March 28, 2011 — PEDiNOL Pharmacal Inc., a leader in the area of podiatric pharmaceuticals, has announced today that they will be offering a full money-back guarantee, The PEDiNOL Promise, for their non prescription products.

Gary Strauss, Chief Executive Officer of PEDiNOL, states, “We are constantly striving to improve our customer service, as it is a vital part of our company and commitment to podiatry, and The PEDiNOL Promise directly reflects this effort. Our goal is to provide quality products coupled with 100% customer satisfaction and our new 90-day money-back guarantee is just one of the many ways we are working to achieve it.”

Under the terms of this offer, if, for any reason, a non prescription PEDiNOL product fails to meet a customer’s expectations, they can simply return the product within 90 days of purchase for a prompt, hassle-free refund of their purchase price (less shipping/handling, if applicable). An original itemized receipt and completed return form must also be sent back with the product. Customers can expect PEDiNOL to process the return within 30 days.

“We are very confident in our products and have stood behind them for over 80 years. The PEDiNOL Promise provides that same level of confidence for our customers” says President Richard Strauss, R.Ph. “Thanks to our money-back guarantee, doctors and patients can purchase PEDiNOL products with complete peace of mind knowing that they have absolutely nothing to lose.”

The PEDiNOL Promise Terms and Conditions are available at:

http://www.pedinol.com/promise.php

About PEDiNOL:

PEDiNOL is based in Farmingdale, NY and was founded in 1925 by Dr. Harry Goldwag, a podiatrist. Since that time, PEDiNOL’s mission has been to provide podiatrists with safe and effective products for their patients’ needs. PEDiNOL’s products include Gris-PEG^® (griseofulvin ultramicrosize) Tablets USP 125mg and 250mg. Fourteen of PEDiNOL’s products bear the APMA Seal of Approval. For more information, please visit our website at www.pedinol.com or call us, toll free, at 1-800-PEDiNOL (733-4665). Live PEDiNOL representatives are available Monday through Friday, 9 AM until 5 PM EST, except holidays.

NWPR0311SD01

PEDiNOL Pharmacal, Inc. is celebrating a special occasion this year. 2010 marks the 85^th anniversary that PEDiNOL has been servicing the podiatry profession.

PEDiNOL was founded in 1925 by Dr. Harry Goldwag. Dr. Goldwag was a pioneer in podiatric education. As a professor at the M.J. Lewis School of Podiatric Medicine, now known as the New York College of Podiatric Medicine, Dr. Goldwag was one of the first podiatrists to have significant experience in both the academic and private practice world of podiatry.

Dr. Goldwag founded PEDiNOL with the idea of providing safe and effective products that specifically address the needs of podiatrists and their patients. To this day, Dr. Goldwag’s idea remains PEDiNOL’s goal.

“Dr. Goldwag had a unique vision,” stated Richard Strauss, R.Ph., President of PEDiNOL. “It has always been PEDiNOL’s mission to continue to fulfill Dr. Goldwag’s vision and bring quality products to the podiatric profession.”

Today, PEDiNOL has a line of 33 products made specifically with podiatrists and their patients’ well being in mind. Fourteen of PEDiNOL’s products contain the prestigious American Podiatric Medical Association (APMA) Seal of Approval. In addition, PEDiNOL is a Corporate Member of the APMA as well as a member of the American Podiatric Medical Student Association Corporate Advisory Board.

PEDiNOL has an extensive infrastructure in place that helps the company provide podiatrists and their patients with the highest quality products and services.

Included in PEDiNOL’s infrastructure is a nationwide sales force which allows podiatrists to have consistent access to the latest information on all PEDiNOL products and patient education materials. “We take a tremendous amount of pride in the professionalism of our sales force,” said Todd Gardner, PEDiNOL’s National Sales Manager. “All PEDiNOL sales representatives go through extensive training which enables them to bring significant value to podiatry practices with their expertise and knowledge.”

PEDiNOL’s website (www.pedinol.com) allows for podiatrists and their patients to access information regarding PEDiNOL products at anytime.

The company’s customer service department addresses any questions pertaining to PEDiNOL products. PEDiNOL’s customer service department includes three registered pharmacists. The customer service department can be reached at 1-800-PEDINOL (733-4665) on Monday through Friday from 9AM EST to 5PM EST, except holidays.

A state-of-the-art warehouse and distribution facility makes PEDiNOL’s products available on a nationwide basis. “Thanks to new technology, we have been able to streamline the packaging and distribution of our products,” said Ed Maciejewski, PEDiNOL’s Director of Warehouse Operations. “This enables us to get our products to customers as quickly as possible.”

PEDiNOL’s main products are manufactured by top pharmaceutical companies. The FDA inspects PEDiNOL’s manufacturers, which ensures the highest quality in PEDiNOL products. Manufacturing facilities go through extensive audits by PEDiNOL’s regulatory affairs department. “The quality of our products is our number one priority at PEDiNOL,” stated Lance Moore, R.Ph., PEDiNOL’s Regulatory Affairs Director. “We make every effort to ensure that PEDiNOL delivers quality products.”

PEDiNOL’s marketing department provides podiatrists with useful materials for distribution in podiatry practices. “We realize that podiatrists and their patients are looking for more than just information on our products,” said Rob Graci, R.Ph., Senior Product Manager at PEDiNOL. “We want to add value to the podiatry office by providing information that would be helpful to both the podiatrist and their patients.”

The company’s business development department regularly conducts extensive research within the podiatry specialty to determine the specific needs of podiatrists and their patients. “It’s very simple. We are a podiatry company,” said Scott Florentino, PEDiNOL’s Manager of Commercial Development. “We want to bring products to podiatrists that will help them treat their patients. In order to find what types of products are needed, we go directly to the source by having in depth discussions with podiatrists from around the country.”

PEDiNOL’s Chief Scientific Officer, Abu Huq, Ph.D., works with manufacturers to help develop new and unique formulations for podiatry patients based on the input of podiatrists.

The company has a Podiatric Medical Advisory Board which includes some of the most renowned podiatry thought leaders in the country.

PEDiNOL attends and supports over 30 podiatry conferences around the country every year.

PEDiNOL’s managed care department works on getting the best possible insurance coverage for PEDiNOL products, allowing for better access to patients. “We realize that insurance coverage is one of the major issues facing podiatrists and their patients today”, said Josie Brown, PEDiNOL’s Manager of Managed Markets. “It is our goal for every patient to have access to our products regardless of what insurance coverage they have.”

“Everyone at PEDiNOL has worked very hard at strengthening our infrastructure to help bring our customers – podiatrists and their patients – the highest quality products and services,” said Gary Strauss, Chief Executive Officer at PEDiNOL. “We believe our infrastructure allows podiatrists to use and recommend PEDiNOL products with confidence knowing that there is a tremendous support system behind the products.”

For more information on PEDiNOL’s products and services, contact PEDiNOL at:

·         Website: www.pedinol.com

·         E-mail: customerservice@pedinol.com

·         Phone: 1-800-PEDINOL(733-4665)

·         Fax: 631-293-7359

FARMINGDALE, NY—July 1, 2010—PEDiNOL Pharmacal Inc. is proud to unveil its newest line of products, PEDiNOL’s Hydro ARMOR Ag Professional Blister Care dressings. These dressings are specially made with a proprietary hydrocolloid adhesive formulation. 

PEDiNOL’s Hydro ARMOR Ag, sterile and latex free dressings, are designed to be flexible and conformable, easily fitting difficult areas of the feet, heels and toes. They provide a waterproof, mechanical barrier to external contaminants, which, if left untreated, can cause infection. Once applied over blisters, the dressings create a moist wound environment which facilitates the healing process of blisters better than conventional bandages. The dressings, which may be left on for up to 7 days, provides around the clock blister care and skin protection.

 “Although blisters may not be the primary reason for a patient to visit their podiatrist, they do often come up in conversation as a secondary ailment”, states Gary Strauss, CEO of PEDiNOL. “Providing specialized products for podiatrists is what our company prides itself on. PEDiNOL’s Hydro ARMOR Ag dressings offer an effective blister care solution which both podiatrists, and their patients, will benefit from.”       

PEDiNOL’s Hydro ARMOR Ag dressings are designed to be patient friendly, allowing podiatrists to provide personalized care for their patient’s blisters. Podiatrists can mix and match the amount of toe and heel dressings they recommend to continue patient care and therapy, according to their patient’s individual needs. Toe and heel dressings will be available for continued patient care exclusively through their foot doctor.

PEDiNOL’s Hydro ARMOR Ag Blister Care Kit is specifically designed for continued at-home patient care and contains 6 heel dressings and 4 toe dressings. PEDiNOL’s Nourishing Cream, which is formulated with Vitamin E and A to help promote healthy skin, is also provided in the kit. Podiatrists may purchase the Blister Care Kit online at www.pedinol.com and direct patients to do the same.

Richard Strauss, R.Ph., President of PEDiNOL, is very confident in the new blister care line stating, “I'm certain customers will be impressed with both the functionality and efficacy of PEDiNOL’s Hydro ARMOR Ag dressings. Podiatrists are seeing the value of continuing patient care with this product and the positive effect it has on patient convenience and satisfaction.”

PEDiNOL’s Hydro ARMOR Ag Dressings are available exclusively from PEDiNOL Pharmacal, Inc. Podiatrists may place an order or learn more about PEDiNOL’s Hydro ARMOR Ag Professional Blister Care Product Line by calling 1-800-PEDiNOL or contacting their PEDiNOL sales representative.

About PEDiNOL:

PEDiNOL is based in Farmingdale, NY and was founded in the 1920’s by Dr. Harry Goldwag, a podiatrist. Since that time, PEDiNOL’s mission has been to provide podiatrists with safe and effective products for their patients’ needs. PEDiNOL’s products include Gris-PEG (griseofulvin ultramicrosize) Tablets USP 125mg; 250mg, Nalfon® (fenoprofen calcium 200 mg and 400 mg capsules) and Fungoid® Tincture (miconazole nitrate 2%). Fourteen of PEDiNOL’s products bear the APMA Seal of Approval. For more information, please visit www.pedinol.com or call 1-800-PEDiNOL.

FARMINGDALE, NY—January 22, 2010—PEDiNOL Pharmacal Inc. has introduced a new product logo in anticipation of their upcoming launch of Nalfon 400 mg. The original Nalfon logo was developed by PEDiNOL in 2005. The new logo, which will be featured on Nalfon 400mg advertisements and sample packaging, is an updated version of the original logo intended to reflect the company’s commitment to innovation and progress. 

Prompted by feedback from their patients, many podiatrists requested the development of a Nalfon 400 mg capsule. “The development of Nalfon 400 mg is a direct result of PEDiNOL’s continual dedication to our customer’s wants and needs” stated Richard Strauss, R.Ph., President of PEDiNOL.

The 3-D blue and green symbols on the new product logo illustrate the signature Nalfon colors.  Chief Executive Officer Gary Strauss states, “The development of Nalfon 400mg reflects who we are, the customers that drive our business and the passion that differentiates us in the area of podiatric pharmaceuticals”.

Please see a sales representative or www.nalfon.com for full prescribing information.

About PEDiNOL:

PEDiNOL is based in Farmingdale, NY, and was founded in 1925 by Dr. Harry Goldwag, a podiatrist. Since that time, PEDiNOL’s mission has been to provide podiatrists with safe and effective products for their patients’ needs. PEDiNOL’s products include Gris-PEG (griseofulvin ultramicrosize) Tablets USP 125mg; 250mg, Nalfon^® 200 (fenoprofen calcium 200 mg capsules) and Fungoid^® Tincture (miconazole nitrate 2%). Fourteen of PEDiNOL’s products bear the APMA Seal of Approval. For more information, please visit www.pedinol.com or call 1-800-PEDiNOL.

About Nalfon:

Nalfon 200 mg is indicated for relief of mild to moderate pain in adults and Nalfon 400 mg is indicated for relief of the signs and symptoms of rheumatoid arthritis and osteoarthritis.

NSAIDs may cause an increased risk of serious cardiovascular thrombotic events, myocardial infarction, and stroke, which can be fatal. This risk may increase with duration of use. Patients with cardiovascular disease or risk factors for cardiovascular disease may be at greater risk.  Nalfon is contraindicated for the treatment of peri-operative pain in the setting of coronary artery bypass graft (CABG) surgery.  NSAIDs cause an increased risk of serious gastrointestinal adverse events including bleeding, ulceration, and perforation of stomach or intestines, which can be fatal. These events can occur at any time during use and without warning symptoms. Elderly patients are at greater risk for serious gastrointestinal events.

Nalfon is contraindicated in patients who have shown hypersensitivity to fenoprofen calcium.  Nalfon should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs. Severe, rarely fatal, anaphylactic-like reactions to NSAIDs have been reported in such patients. Nalfon is contraindicated for the treatment of peri-operative pain in the setting of coronary artery bypass graft (CABG) surgery. Nalfon is contraindicated in patients with a history of significantly impaired renal function.

FARMINGDALE, NY— January 7, 2010— PEDiNOL Pharmacal Inc. was founded in 1925 by Dr. Harry Goldwag, a podiatrist and esteemed professor of M. Lewi School of Podiatry (now known as the New York College of Podiatric Medicine). PEDiNOL’s mission has been to provide podiatrists with safe and effective products for their patients’ needs.

“We are honored to have been able to serve podiatrists for 85 years,” said Gary Strauss, Chief Executive Officer of PEDiNOL. “The podiatry specialty has played such a vital role in the medical community by diagnosing and treating conditions affecting the foot and ankle. In that aspect, we hope PEDiNOL has helped podiatrists and their patients.”

“We’ve been very fortunate to have the support of the podiatric community for so many years,” stated Richard Strauss, R.Ph., President of PEDiNOL. “It was Dr. Goldwag’s dream to have a pharmaceutical company which focused exclusively on the podiatric specialty. During the past 85 years, we feel we’ve been able to keep his dream alive.”

PEDiNOL is one of the few privately owned specialty pharmaceutical companies in existence. PEDiNOL is currently a corporate sponsor of the American Podiatric Medical Association and the American Podiatric Medical Students Association. We also have a nationwide sales force to provide podiatrists with the most up to date information on PEDiNOL products and support over 40 podiatric educational seminars each year.

For more information regarding PEDiNOL, please visit our newly renovated website at www.pedinol.com.

About PEDiNOL:

PEDiNOL is based in Farmingdale, NY and was founded in the 1920’s by Dr. Harry Goldwag, a podiatrist. Since that time, PEDiNOL’s mission has been to provide podiatrists with safe and effective products for their patients’ needs. PEDiNOL’s products include Gris-PEG (griseofulvin ultramicrosize) Tablets USP 125mg; 250mg, Nalfon® (fenoprofen calcium 200 mg and 400 mg capsules) and Fungoid® Tincture (miconazole nitrate 2%). Fourteen of PEDiNOL’s products bear the APMA Seal of Approval. For more information, please visit www.pedinol.com or call 1-800-PEDiNOL.

FARMINGDALE, NY— December 1, 2009—PEDiNOL Pharmacal Inc. will begin marketing Lactinol HX, a new formulation of the Lactinol brand moisturizers.

Lactinol HX uses the moisturizing power of lactic acid to increase skin water content, debride dead skin cells and promote complete skin health. Unlike PEDiNOL’s popular prescription moisturizer, Lactinol-E Creme, Lactinol HX is available without a prescription.

“We are very excited to offer Lactinol HX to podiatrists and their patients,” states Richard Strauss, R.Ph., President of PEDiNOL. “The Lactinol brand has always represented the highest quality in skin health to the podiatric specialty. Lactinol HX is available without a prescription which will provide podiatric patients with the trusted Lactinol quality without the concerns of drug formulary coverage and costly co-pays.”

PEDiNOL will be providing podiatrists with coupons and samples of Lactinol HX. Patients can purchase Lactinol HX from their local pharmacies and through their podiatrist. To learn more about the newly formulated Lactinol HX and to place an order, please visit PEDiNOL’s website at www.pedinol.com or call PEDiNOL’s toll-free phone number, 1-800-PEDiNOL (733-4665).

About PEDiNOL:

PEDiNOL is based in Farmingdale, NY, and was founded in 1925 by Dr. Harry Goldwag, a podiatrist. Since that time, PEDiNOL’s mission has been to provide podiatrists with safe and effective products for their patients’ needs. PEDiNOL’s products include Gris-PEG (griseofulvin ultramicrosize) Tablets USP 125mg; 250mg, Nalfon^® 200 (fenoprofen calcium 200 mg capsules) and Fungoid^®Tincture (miconazole nitrate 2%).

FARMINGDALE, NY— November 17, 2009—PEDiNOL Pharmacal Inc. is proud to announce the launch of their new and improved website, www.pedinol.com. Visitors to www.pedinol.com can now benefit from improved functionality, including:

• Direct on-line product ordering
• Frequent updates on product news and promotional campaigns
• Improved customer feedback mechanisms
• Current product information and pictures
• In-depth account of PEDiNOL’s long history of service to podiatrists

“We are very excited about PEDiNOL’s new and improved website,” said President of PEDiNOL Richard Strauss, R.Ph. “At PEDiNOL, we have always been focused on serving podiatrists and their patients. The new www.pedinol.com gives us more effective ways to communicate with our customers and provide them with the quality products and service that they deserve.”

To mark this launch, PEDiNOL will be announcing significant price reductions and discount programs. Please visit www.pedinol.com periodically to learn more.

About PEDiNOL:

PEDiNOL is based in Farmingdale, NY and was founded in the 1920’s by Dr. Harry Goldwag, a podiatrist. Since that time, PEDiNOL’s mission has been to provide podiatrists with safe and effective products for their patients’ needs. PEDiNOL’s products include Gris-PEG (griseofulvin ultramicrosize) Tablets USP 125mg; 250mg, Nalfon® (fenoprofen calcium 200 mg and 400 mg capsules) and Fungoid® Tincture (miconazole nitrate 2%). Fourteen of PEDiNOL’s products bear the APMA Seal of Approval. For more information, please visit www.pedinol.com or call 1-800-PEDiNOL.

FARMINGDALE, NY—October 12, 2009—PEDiNOL Pharmacal Inc. announced that it has received FDA approval for Nalfon (fenoprofen calcium) 400mg capsules.  Nalfon 400mg capsules are indicated for the relief of signs and symptoms of rheumatoid arthritis or osteoarthritis in adults with a recommended dose is 400 to 600 mg given orally, 3 or 4 times a day.

Nalfon 400mg capsules offer podiatrists and their patients an improvement in Nalfon’s dosing. One capsule instead of two means there are fewer capsules for the patient to take daily.

“Nalfon 400mg is another wonderful addition to PEDiNOL’s family of podiatry products,” stated Richard Strauss, R.Ph., President of PEDiNOL. “Our mission is to serve podiatrists. We value our customer’s input so when podiatrists asked for a 400mg capsule for improved dosing, we started development on it.”

PEDiNOL plans to launch Nalfon 400mg in early 2010. Nalfon 400mg will be available in 90 count bottles. Nalfon 200mg capsules are also available for dosing flexibility.

Please see a sales representative or www.nalfon.com for full prescribing information.

About PEDiNOL:

Pedinol is based in Farmingdale, NY and was founded in the 1920’s by Dr. Harry Goldwag, a podiatrist. Since that time, PEDiNOL’s mission has been to provide podiatrists with safe and effective products for their patients’ needs. PEDiNOL’s products include Gris-PEG (griseofulvin ultramicrosize) Tablets USP 125mg; 250mg, Nalfon® 200 (fenoprofen calcium 200 mg capsules) and Fungoid® Tincture (miconazole nitrate 2%). Fourteen of PEDiNOL’s products bear the APMA Seal of Approval. For more information, please visit www.pedinol.com or call 1-800-PEDiNOL.

About Nalfon:

Nalfon is indicated for relief of mild to moderate pain in adults and for relief of the signs and symptoms of rheumatoid arthritis and osteoarthritis.

NSAIDs may cause an increased risk of serious cardiovascular thrombotic events, myocardial infarction, and stroke, which can be fatal. This risk may increase with duration of use. Patients with cardiovascular disease or risk factors for cardiovascular disease may be at greater risk.  Nalfon is contraindicated for the treatment of peri-operative pain in the setting of coronary artery bypass graft (CABG) surgery.  NSAIDs cause an increased risk of serious gastrointestinal adverse events including bleeding, ulceration, and perforation of stomach or intestines, which can be fatal. These events can occur at any time during use and without warning symptoms. Elderly patients are at greater risk for serious gastrointestinal events.

Nalfon is contraindicated in patients who have shown hypersensitivity to fenoprofen calcium.  Nalfon should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs. Severe, rarely fatal, anaphylactic-like reactions to NSAIDs have been reported in such patients. Nalfon is contraindicated for the treatment of peri-operative pain in the setting of coronary artery bypass graft (CABG) surgery.

Nalfon is contraindicated in patients with a history of significantly impaired renal function.